Pengaruh Return on Assets (Roa), Return on Equity (Roe), Debt to Equity Ratio (Der), Earning Per Share (Eps), Dan Price Earning Ratio (Per) Terhadap Return Saham

One of the investor's aims in investing on emiten is to get a return. To get a stock's return, the loss risks cannot be denied, and it is affected by the stock's price fluctuation that is cannot be determined. However, as the stocks exchange is rapidly developed, it does not mean that the risk limit cannot be decreased. The technical and fundamental analysis have become a solution for the investor to predict the stocks' price. Specifically, this research discusses about the fundamental analysis by appraising the companies' performance which is depicted on the companies' financial report with ratio as a tool to analyze the financial report. By using the financial ratio, it can be seen and it can be an image for the investors about the good and bad images of the companies' condition, so that it would be a basis for the investors for choosing the companies that have a higher return level than the loss risks. The aim of this research are too understand the influences of Return On Assets (ROA), Return On Equity (ROE), Debt to Equity Ratio (DER), Earning Per Share (EPS), and Price Earning Ratio (PER) toward Stock's Return. The population in this research is the companies that are listed on the sub-sectored stocks in property and real estate during the period of 2012-2016. There are 22 companies that are matched with the following criteria as the research's sample. The quantitative analysis use the classic assumptions' test, coefficient correlation determination coefficient, simple regression, double regression, and significances test (uji t and F). The result from this research shows that Return on Assets (ROA) affects the stock's return. Return on Equity (RO) affects the stock's return. Debt to Equity Ratio (DER) is not affected the stock's return. Earning Per Share (EPS) affects the stock's return. Price Earning Ration (PER) affects the stock's return. The dependent variable simultaneously influence the stock's return. As a suggestion, there will be better if a company make a decision to efficient the budget in order to improve the profits, identify and group the assets that either have a potential or not which are used to support the companies' operational procedure and to optimize the modal's using

Pengaruh Return on Assets (Roa), Return on Equity (Roe), Debt to Equity Ratio (Der), Earning Per Share (Eps), Dan Price Earning Ratio (Per) Terhadap Return Saham

One of the investor\u27s aims in investing on emiten is to get a return. To get a stock\u27s return, the loss risks cannot be denied, and it is affected by the stock\u27s price fluctuation that is cannot be determined. However, as the stocks exchange is rapidly developed, it does not mean that the risk limit cannot be decreased. The technical and fundamental analysis have become a solution for the investor to predict the stocks\u27 price. Specifically, this research discusses about the fundamental analysis by appraising the companies\u27 performance which is depicted on the companies\u27 financial report with ratio as a tool to analyze the financial report. By using the financial ratio, it can be seen and it can be an image for the investors about the good and bad images of the companies\u27 condition, so that it would be a basis for the investors for choosing the companies that have a higher return level than the loss risks. The aim of this research are too understand the influences of Return On Assets (ROA), Return On Equity (ROE), Debt to Equity Ratio (DER), Earning Per Share (EPS), and Price Earning Ratio (PER) toward Stock\u27s Return. The population in this research is the companies that are listed on the sub-sectored stocks in property and real estate during the period of 2012-2016. There are 22 companies that are matched with the following criteria as the research\u27s sample. The quantitative analysis use the classic assumptions\u27 test, coefficient correlation determination coefficient, simple regression, double regression, and significances test (uji t and F). The result from this research shows that Return on Assets (ROA) affects the stock\u27s return. Return on Equity (RO) affects the stock\u27s return. Debt to Equity Ratio (DER) is not affected the stock\u27s return. Earning Per Share (EPS) affects the stock\u27s return. Price Earning Ration (PER) affects the stock\u27s return. The dependent variable simultaneously influence the stock\u27s return. As a suggestion, there will be better if a company make a decision to efficient the budget in order to improve the profits, identify and group the assets that either have a potential or not which are used to support the companies\u27 operational procedure and to optimize the modal\u27s using

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

SummaryBackground Azithromycin has been proposed as a treatment for COVID-19 on the basis of its immunomodulatoryactions. We aimed to evaluate the safety and efficacy of azithromycin in patients admitted to hospital with COVID-19.Methods In this randomised, controlled, open-label, adaptive platform trial (Randomised Evaluation of COVID-19Therapy [RECOVERY]), several possible treatments were compared with usual care in patients admitted to hospitalwith COVID-19 in the UK. The trial is underway at 176 hospitals in the UK. Eligible and consenting patients wererandomly allocated to either usual standard of care alone or usual standard of care plus azithromycin 500 mg once perday by mouth or intravenously for 10 days or until discharge (or allocation to one of the other RECOVERY treatmentgroups). Patients were assigned via web-based simple (unstratified) randomisation with allocation concealment andwere twice as likely to be randomly assigned to usual care than to any of the active treatment groups. Participants andlocal study staff were not masked to the allocated treatment, but all others involved in the trial were masked to theoutcome data during the trial. The primary outcome was 28-day all-cause mortality, assessed in the intention-to-treatpopulation. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936.Findings Between April 7 and Nov 27, 2020, of 16 442 patients enrolled in the RECOVERY trial, 9433 (57%) wereeligible and 7763 were included in the assessment of azithromycin. The mean age of these study participants was65·3 years (SD 15·7) and approximately a third were women (2944 [38%] of 7763). 2582 patients were randomlyallocated to receive azithromycin and 5181 patients were randomly allocated to usual care alone. Overall,561 (22%) patients allocated to azithromycin and 1162 (22%) patients allocated to usual care died within 28 days(rate ratio 0·97, 95% CI 0·87–1·07; p=0·50). No significant difference was seen in duration of hospital stay (median10 days [IQR 5 to >28] vs 11 days [5 to >28]) or the proportion of patients discharged from hospital alive within 28 days(rate ratio 1·04, 95% CI 0·98–1·10; p=0·19). Among those not on invasive mechanical ventilation at baseline, nosignificant difference was seen in the proportion meeting the composite endpoint of invasive mechanical ventilationor death (risk ratio 0·95, 95% CI 0·87–1·03; p=0·24).Interpretation In patients admitted to hospital with COVID-19, azithromycin did not improve survival or otherprespecified clinical outcomes. Azithromycin use in patients admitted to hospital with COVID-19 should be restrictedto patients in whom there is a clear antimicrobial indication